Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Gene therapy and treatment trials

MacLaren RE. and Cehajic-Kapetanovic J., (2022), Clinical Ophthalmic Genetics and Genomics, 63 - 66

Rapid Quantification of the Binocular Visual Field for Clinical Trials: Performance of a Modified Esterman Supra-Threshold Test Implemented with the Open Perimetry Interface.

Andrews CD. et al, (2022), Clin Ophthalmol, 16, 1513 - 1523

RNA gene editing in the eye and beyond: The neglected tool of the gene editing armatorium?

Han RC. and MacLaren RE., (2022), International Review of Cell and Molecular Biology

Retinal cadherins and the retinal cadherinopathies: current concepts and future directions

YUSUF I. et al, (2021), Progress in Retinal and Eye Research

Clinical applications of microperimetry in RPGR ‐related retinitis pigmentosa: a review

Buckley TMW. et al, (2021), Acta Ophthalmologica, 99, 819 - 825

Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa

Orlans HO. et al, (2021), Nature Communications, 12

In Silico Analysis of Pathogenic CRB1 Single Nucleotide Variants and Their Amenability to Base Editing as a Potential Lead for Therapeutic Intervention.

Bellingrath J-S. et al, (2021), Genes (Basel), 12

First-In-Human Robot-Assisted Subretinal Drug Delivery Under Local Anaesthesia A Randomised Clinical Trial.

Cehajic-Kapetanovic J. et al, (2021), Am J Ophthalmol

Structural and Functional Characteristics of Color Vision Changes in Choroideremia

Jolly JK. et al, (2021), Frontiers in Neuroscience, 15, 1287 - 1287

CRISPR Systems Suitable for Single AAV Vector Delivery.

Stevanovic M. et al, (2021), Curr Gene Ther

Endpoints for Measuring Efficacy in Clinical Trials for Inherited Retinal Disease.

Chung DC. et al, (2021), International ophthalmology clinics, 61, 63 - 78

RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.

van Rijssen TJ. et al, (2021), Retina, 41, 2122 - 2131

Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina

Chandler LC. et al, (2021), Molecular Therapy - Methods & Clinical Development, 22, 52 - 65

Therapy Approaches for Stargardt Disease

Piotter E. et al, (2021), Biomolecules, 11, 1179 - 1179

Insights on the Regeneration Potential of Müller Glia in the Mammalian Retina

Salman A. et al, (2021), Cells, 10, 1957 - 1957

Chimeric human opsins as optogenetic light sensitisers.

Hickey DG. et al, (2021), J Exp Biol, 224

Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia

Fry LE. et al, (2021), Translational Vision Science & Technology, 10, 12 - 12

Prevalence and Phenotype Associations of Complement Factor I Mutations in Geographic Atrophy.

Khan AH. et al, (2021), Hum Mutat

Microperimetry Hill of Vision and Volumetric Measures of Retinal Sensitivity

Josan AS. et al, (2021), Translational Vision Science & Technology, 10, 12 - 12

Chimeric human opsins as optogenetic light sensitisers

HANKINS M. et al, (2021), The Journal of Experimental Biology

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?